Experimental Hematology & Oncology

Experimental Hematology & Oncology

实验血液学和肿瘤学

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Experimental Hematology & Oncology》是由BioMed Central出版社于2012年创办的英文国际期刊(ISSN: 2162-3619,E-ISSN: 2162-3619),该期刊长期致力于血液学领域的创新研究,主要研究方向为Medicine-Oncology。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比61.97%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在71篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Experimental Hematology & Oncology审稿周期约为 6 Weeks 。该刊近年未被列入国际预警名单,年发文量约71篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 71 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 9 / 97

91.2%

学科:ONCOLOGY SCIE Q1 32 / 322

90.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 13 / 97

87.11%

学科:ONCOLOGY SCIE Q1 36 / 322

88.98%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:12.6 SJR:2.384 SNIP:1.583
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 42 / 404

89%

大类:Medicine 小类:Hematology Q1 17 / 137

87%

大类:Medicine 小类:Cancer Research Q1 35 / 230

85%

期刊发文

  • ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner

    Author: Wang, Weijian; Huang, Qibo; Liao, Zhibin; Zhang, Hongwei; Liu, Yachong; Liu, Furong; Chen, Xiaoping; Zhang, Bixiang; Chen, Yan; Zhu, Peng

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00370-2

  • Breast cancer heterogeneity and its implication in personalized precision therapy

    Author: Guo, Liantao; Kong, Deguang; Liu, Jianhua; Zhan, Ling; Luo, Lan; Zheng, Weijie; Zheng, Qingyuan; Chen, Chuang; Sun, Shengrong

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00363-1

  • CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia

    Author: Hu, Xinting; Han, Yang; Liu, Jiarui; Wang, Hua; Tian, Zheng; Zhang, Xin; Zhang, Ya; Wang, Xin

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00364-0

  • Caspase-8 contributes to an immuno-hot microenvironment by promoting phagocytosis via an ecto-calreticulin-dependent mechanism

    Author: Gong, Zhihua; Jia, Qingzhu; Guo, Jinming; Li, Chongyi; Xu, Shouxia; Jin, Zheng; Chu, Han; Wan, Yisong Y.; Zhu, Bo; Zhou, Yi

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00371-1

  • CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway

    Author: Chen, Erbao; He, Yu; Jiang, Jing; Yi, Jing; Zou, Zhilin; Song, Qiuzi; Ren, Qingqi; Lin, Zewei; Lu, Yi; Liu, Jikui; Zhang, Jian

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00366-y

  • Dlk1 maintains adult mice long-term HSCs by activating Notch signaling to restrict mitochondrial metabolism

    Author: Huang, Deyu; Han, Yingli; Tang, Tian; Yang, Lin; Jiang, Penglei; Qian, Wenchang; Zhang, Zhaoru; Qian, Xinyue; Zeng, Xin; Qian, Pengxu

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-022-00369-9

  • Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment

    Author: Yan, Ting; Zhu, Lingfeng; Chen, Jin

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-023-00373-7

  • GPR109A controls neutrophil extracellular traps formation and improve early sepsis by regulating ROS/PAD4/Cit-H3 signal axis

    Author: Guo, Wenjin; Gong, Qian; Zong, Xiaofeng; Wu, Dianjun; Li, Yuhang; Xiao, Huijie; Song, Jie; Zhang, Sheng; Fu, Shoupeng; Feng, Zhichun; Zhuang, Lu

    Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2023; Vol. 12, Issue 1, pp. -. DOI: 10.1186/s40164-023-00376-4